Microbial Lipase Market Scope
Microbial Lipase are enzymes which hydrolyse fats into fatty acids, monoacylglycerol, diacylglycerol as well as glycerol at water lipid interface. Other than Hydrolysis they show excellent properties in esterification, aminolysis and alcoholysis activity. The continuous research and development has led to new efficient ways of purification and generation of lipase, including the recent one with molecular strategies. Microbial Lipase because of their broad scale enzymatic properties are ideal for wide variety of industrial applications which include dairy and food additives, design of drugs, organic synthesis, etc. Geographically, Asia Pacific was the leading market in the use of Microbial Lipase followed by North America.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
Key Companies Profiled | Amano Enzymes (Japan), Koninklijke DSM N.V. (Netherlands), Novozymes A/S (Denmark), Chr. Hansen Holding A/S (Denmark), Aumgene Biosciences (India), Advanced Enzymes (India), DuPont de Nemours, Inc. (United States), Associated British Foods (United Kingdom), Meito Sangyo Co., Ltd (Japan), Biocatalysts Ltd. (United Kingdom) and Enzyme Development Corporation (United States) |
CAGR | 6.2% |
Research Analyst at AMA estimates that United States Vendors will contribute to the maximum growth of Global Microbial Lipase market throughout the predicted period.
Amano Enzymes (Japan), Koninklijke DSM N.V. (Netherlands), Novozymes A/S (Denmark), Chr. Hansen Holding A/S (Denmark), Aumgene Biosciences (India), Advanced Enzymes (India), DuPont de Nemours, Inc. (United States), Associated British Foods (United Kingdom), Meito Sangyo Co., Ltd (Japan), Biocatalysts Ltd. (United Kingdom) and Enzyme Development Corporation (United States) are some of the key players that are part of study coverage. Additionally, the Vendors which are also part of the research are Creative Enzymes (United States), AB Enzymes (Germany) and Aum Enzymes (India).
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.
Segmentation Overview
The study have segmented the market of Global Microbial Lipase market by Type and Region with country level break-up.
On the basis of geography, the market of Microbial Lipase has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
region held largest market share in the year 2023.
Market Leaders and their expansionary development strategies
In In August 2023, the U.S. FDA approved the expanded use of RELiZORB, developed by Alcresta Therapeutics, Inc., to provide enteral feeding in children between 2 to<5 years of age. This approval is expected to have a positive impact on market growth.
In Enzyme specialists, Biocatalysts Ltd, announce the launch of their new enzyme Lipomod® 767P, it is non-genetically modified microbial lipase preparation suitable for both the hydrolysis and esterification of oils and fats. Its broad spectrum pH profile means it can be used in applications across a wide range of substrate types.
Different Microbial Lipase and Enzymes are compiled by FDA under 21 CFR 172 and 173, 21 CFR184 Regulations.
Influencing Trend:
Recent Pandemic has resulted in Boom of Cleaning Industry which is Prime End User of Microbial Lipase
Market Growth Drivers:
Wide Applicability for End Use Industry and Growing Preference for Fungal lipase based Microbial Lipase by Cosmetics and Pharmaceuticals Industry
Challenges:
Presence of Counterfeit Products
Restraints:
Popularity of Plant and Animal Lipase May Restrain its Demand and Irregular Regulatory Framework
Opportunities:
Expansion and Growth of Food and Beverages Market will Draw Higher Demand for Microbial Lipase
Key Target Audience
Microbial Lipase Manufacturers, Suppliers and Distributors, New Entrants/Investors, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industries